Dr Reddys Lab Inks Licensing Pact With Slayback Pharma

Dr Reddys Lab Inks Licensing Pact With Slayback Pharma

By, Admin 2 August 2022

As Per Industry Estimates, The Value Of The Total Addressable Market For The Eye Drop In The Us Is Around Usd 130 Million For The 52 Weeks Ending June 12, 2022. Dr Reddy'S Laboratories On Saturday Said It Has Entered Into A Pact With Usbased Slayback Pharma To Acquire Rights Of A Medication To Relieve Redness Of The Eyes. The Company Has Inked A Licensing Pact With The Newjersey-Based Drug Firm To Acquire Rights In Brimonidine Tartrate Ophthalmic Solution 0.025 Per Cent, The Hyderabad-Based Firm Said In A Statement. The Company'S Product Is Equivalent To Lumify, An Over-The-Counter (Otc) Eyedrop, That Can Be Used To Relieve Redness Of The Eye Due To Minor Eye Irritations. The Agreement Also Provides Dr Reddy'S Exclusive Rights To The Product Outside The Us, Dr Reddy'S Laboratories Said. As Per Industry Estimates, The Value Of The Total Addressable Market For This Product In The Us Is Around Usd 130 Million For The 52 Weeks Ending June 12, 2022

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!